Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03104413
Brief Title: A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment

First Submitted : April 4, 2017
First Submitted that Met QC Criteria : April 4, 2017
First Posted : April 7, 2017

Results First Submitted : March 31, 2022
Results First Posted with QC Comments : April 28, 2022
Results First Submitted that Met QC Criteria : May 19, 2022
Results First Posted : June 14, 2022

Certification/Extension First Submitted : July 16, 2021
Certification/Extension First Submitted that Met QC Criteria : May 19, 2022
Certification/Extension First Posted : June 14, 2022

Last Update Submitted that Met QC Criteria : May 19, 2022
Last Update Posted : June 14, 2022